Swipe om te navigeren naar een ander artikel
The online version of this article (https://doi.org/10.1007/s10803-019-04200-z) contains supplementary material, which is available to authorized users.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This study examined the experiences of Autism Spectrum Disorder (ASD) genetic testing among parents of children with ASD. A nationwide sample of 552 parents of children with ASD completed an online survey. Nearly one-quarter (22.5%) of the parents reported that their affected children had undergone ASD genetic testing. The testing utilization was associated with awareness of ASD genetic testing and whether information was received from healthcare providers. Among parents whose children with ASD were tested, 37.6% had negative experiences, which mainly due to lack of perceived testing benefits to their affected children and unpleasant testing experiences with healthcare providers. To provide better healthcare services, it is critical to ensure parents understand the purposes, benefits, and results of ASD genetic testing.
Log in om toegang te krijgen
Met onderstaand(e) abonnement(en) heeft u direct toegang:
Ajzen, I. (1991). The theory of planned behavior. Organizational Behavior and Human Decision Processes, 50(2), 179–211. CrossRef
Altiere, M. J., & von Kluge, S. (2009). Family functioning and coping behaviors in parents of children with autism. Journal of Child and Family Studies, 18(1), 83. CrossRef
American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders, text revision (DSM-IV-TR) (4th ed.). Washington, DC: American Psychiatric Publishing.
American Psychiatric Association. (2013). Neurodevelopmental disorders. Diagnostic and statistical manual of mental disorders (5th ed.). Washington, DC: American Psychiatric Publishing. CrossRef
Baio, J. (2014). Prevalence of autism spectrum disorder among children aged 8 years-autism and developmental disabilities monitoring network, 11 sites, United States, 2010.
Baio, J., Wiggins, L., Christensen, D. L., Maenner, M. J., Daniels, J., Warren, Z., et al. (2018). Prevalence of autism spectrum disorder among children aged 8 years: Autism and developmental disabilities monitoring network, 11 sites, United States, 2014. MMWR Surveillance Summaries, 67(6), 1–23. https://doi.org/10.15585/mmwr.ss6706a1. PubMedCentralCrossRefPubMed
Bandura, A. (1986). Social foundations of thought and action: A social cognitive theory. Englewood Cliffs: Prentice-Hall Inc.
Centers for Disease Control and Prevention. (2018). Research on autism spectrum disorder. Retrieved August 31, 2019 from https://www.cdc.gov/ncbddd/autism/research.html.
Centers for Disease Control and Prevention. (2019). Autism spectrum disorder (ASD) data & statistics. Retrieved August 31, 2019 from https://www.cdc.gov/ncbddd/autism/data.html.
Cuccaro, M. L., Czape, K., Alessandri, M., Lee, J., Deppen, A. R., Bendik, E., et al. (2014). Genetic testing and corresponding services among individuals with autism spectrum disorder (ASD). American Journal of Medical Genetics Part A, 164(10), 2592–2600. CrossRef
eviCore healthcare. (2019). Genetic tesing for autism. Retrieved August 31, 2019 from https://www.evicore.com/-/media/files/evicore/clinical-guidelines/solution/lab-management/healthplan/genetic-testing-for-autism.pdf.
Harrington, J. W., Rosen, L., Garnecho, A., & Patrick, P. A. (2006). Parental perceptions and use of complementary and alternative medicine practices for children with autistic spectrum disorders in private practice. Journal of Developmental and Behavioral Pediatrics, 27(2), S156–S161. PubMedCrossRef
Hus, V., Pickles, A., Cook, E. H., Risi, S., & Lord, C. (2007). Using the autism diagnostic interview: Revised to increase phenotypic homogeneity in genetic studies of autism. Biological Psychiatry, 61(4), 438–448. https://doi.org/10.1016/j.biopsych.2006.08.044. PubMedCrossRef
Indiana Medicaid. (2019). Indiana health coverage programs (IHCP) fee schedules. Retrieved August 31, 2019 from http://provider.indianamedicaid.com/ihcp/Publications/MaxFee/fee_home.asp.
Interactive Autism Network. (2016). Interactive autism network infographic. Retrieved August 31, 2019 from https://iancommunity.org/interactive-autism-network-infographic.
Janz, N. K., & Becker, M. H. (1984). The health belief model: A decade later. Health Education & Behavior, 11(1), 1–47.
Jeste, S. S. (2011). The neurology of autism spectrum disorders. Current Opinion in Neurology, 24(2), 132–139. https://doi.org/10.1097/WCO.0b013e3283446450. PubMedPubMedCentralCrossRef
Lagos, V. I., Perez, M. A., Ricker, C. N., Blazer, K. R., Santiago, N. M., Feldman, N., et al. (2008). Social-cognitive aspects of underserved Latinas preparing to undergo genetic cancer risk assessment for hereditary breast and ovarian cancer. Psycho-Oncology, 17(8), 774–782. https://doi.org/10.1002/pon.1358. PubMedCrossRef
Lee, H., Marvin, A. R., Watson, T., Piggot, J., Law, J. K., Law, P. A., et al. (2010). Accuracy of phenotyping of autistic children based on internet implemented parent report. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 153(6), 1119–1126.
Maski, K. P., Jeste, S. S., & Spence, S. J. (2011). Common neurological co-morbidities in autism spectrum disorders. Current Opinion in Pediatrics, 23(6), 609–615. https://doi.org/10.1097/MOP.0b013e32834c9282. PubMedPubMedCentralCrossRef
Michelson, D., Shevell, M., Sherr, E., Moeschler, J., Gropman, A., & Ashwal, S. (2011). Evidence report: Genetic and metabolic testing on children with global developmental delay: Report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology, 77(17), 1629–1635. PubMedCrossRef
Miller, D. T., Adam, M. P., Aradhya, S., Biesecker, L. G., Brothman, A. R., Carter, N. P., et al. (2010). Consensus statement: Chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. The American Journal of Human Genetics, 86(5), 749–764. https://doi.org/10.1016/j.ajhg.2010.04.006. PubMedCrossRef
Regence. (2018). Chromosomal microarray analysis (CMA) for the genetic evaluation of patients with developmental delay/intellectual disability, autism spectrum disorder, or congenital anomalies. Retrieved August 31, 2019 from http://blue.regence.com/trgmedpol/geneticTesting/gt58.pdf.
Reiff, M., Giarelli, E., Bernhardt, B. A., Easley, E., Spinner, N. B., Sankar, P. L., et al. (2015). Parents’ perceptions of the usefulness of chromosomal microarray analysis for children with autism spectrum disorders. Journal of Autism and Developmental Disorders, 45(10), 3262–3275. PubMedPubMedCentralCrossRef
UnitedHealthcare. (2019). Chromosome microarray testing. Retrieved August 31, 2019 from https://www.uhcprovider.com/content/dam/provider/docs/public/policies/medicaid-comm-plan/chromosome-microarray-testing-cs.pdf.
Utah Department of Health. (2019). Bureau of coverage and reimbursement policy: Coverage and reimbursement fee schedule. Retrieved August 31, 2019 from https://health.utah.gov/stplan/lookup/FeeScheduleDownload.php.
Weinstein, V., Tanpaiboon, P., Chapman, K. A., Ah Mew, N., & Hofherr, S. (2017). Do the data really support ordering fragile X testing as a first-tier test without clinical features? [Original Research Article]. Genetics in Medicine, 19, 1317. https://doi.org/10.1038/gim.2017.64. PubMedPubMedCentralCrossRef
Wydeven, K. V., Kwan, A., Hardan, A. Y., & Bernstein, J. A. (2012). Underutilization of genetics services for autism: The importance of parental awareness and provider recommendation. Journal of Genetic Counseling, 21(6), 803–813. CrossRef
- Genetic Testing Experiences Among Parents of Children with Autism Spectrum Disorder in the United States
Shweta U. Dhar
Tanya N. Eble
- Springer US